|
End-of-day quote
Shenzhen S.E.
04/09/2026
|
5-day change | 1st Jan Change | ||
| 8.970 CNY | +0.22% |
|
-0.88% | -17.33% |
| Market Cap | 4.48B 667M 574M 540M 494M 923M 63.02B 926M 6.39B 2.48B 32.33B 2.51B 2.45B 104B | P/E 2024 |
224x | P/E 2025 | 67.8x |
|---|---|---|---|---|---|
| Enterprise Value | 4.41B 657M 565M 532M 486M 909M 62B 911M 6.28B 2.44B 31.81B 2.47B 2.41B 102B | EV / Sales 2024 |
6.57x | EV / Sales 2025 | 5.78x |
| Free-Float |
60.48% | Yield 2024 |
0.56% | Yield 2025 | 1.38% |
| 1 day | +0.22% | ||
| 1 week | -0.88% | ||
| Current month | +0.79% | ||
| 1 month | +0.34% | ||
| 3 months | +3.58% | ||
| 6 months | -19.26% | ||
| Current year | -17.33% |
| 1 week | 8.73 |  | 9.15 |
| 1 month | 8.51 | | 9.68 |
| Current year | 7.66 | | 14.47 |
| 1 year | 7.66 | | 15.21 |
| 3 years | 6.79 | | 17.49 |
| 5 years | 5.64 | | 19.64 |
| 10 years | 5.01 | | 20.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Rong Huang Xu
CEO | Chief Executive Officer | 34 | 16/07/2025 |
Xi Liang Chen
DFI | Director of Finance/CFO | 54 | 15/06/2009 |
Ru Qing Yao
PRN | Corporate Officer/Principal | 43 | 01/06/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Xi Liang Chen
BRD | Director/Board Member | 54 | 15/06/2009 |
Bei Jing Lu
BRD | Director/Board Member | 43 | 27/06/2022 |
Rong Huang Xu
CHM | Chairman | 34 | 16/07/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 07/02/24 | Buy | Chief Financial Officer | 42,000 | 0.0188% | ||
| 14/06/23 | Buy | Chief Financial Officer | 42,000 | 0.0188% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.22% | -0.88% | +2.16% | -20.72% | 665M | |
| -1.67% | -3.04% | +53.30% | +104.03% | 1,034B | |
| -1.06% | +2.72% | +54.02% | +71.35% | 671B | |
| -1.58% | +0.17% | +20.15% | +75.17% | 460B | |
| +0.14% | -0.47% | +29.49% | +38.56% | 353B | |
| -1.33% | +4.72% | +24.69% | +45.55% | 309B | |
| -1.15% | +0.30% | -1.49% | +12.31% | 255B | |
| -1.61% | +0.98% | +55.89% | +71.90% | 240B | |
| -0.88% | +1.15% | -17.09% | -54.39% | 207B | |
| -0.40% | +3.33% | +33.49% | +100.29% | 188B | |
| Average | -0.90% | +1.22% | +25.46% | +44.40% | 371.74B | |
| Weighted average by Cap. | -1.17% | +1.04% | +36.16% | +66.06% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 688M 102M 88.16M 82.94M 75.77M 142M 9.67B 142M 980M 380M 4.96B 385M 376M 15.99B | 925M 138M 118M 111M 102M 191M 13B 191M 1.32B 511M 6.67B 517M 506M 21.49B |
| Net income | 20.5M 3.05M 2.63M 2.47M 2.26M 4.22M 288M 4.24M 29.21M 11.33M 148M 11.46M 11.21M 476M | 81.67M 12.17M 10.47M 9.85M 9M 16.83M 1.15B 16.88M 116M 45.16M 589M 45.68M 44.68M 1.9B |
| Net Debt | 58.68M 8.74M 7.52M 7.08M 6.46M 12.09M 825M 12.13M 83.62M 32.45M 423M 32.82M 32.1M 1.36B | -72.61M -10.82M -9.31M -8.76M -8M -14.96M -1.02B -15M -103M -40.15M -524M -40.61M -39.73M -1.69B |
Employees
1,434
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/09/26 | CN¥8.970 | +0.22% | 10,395,210 |
| 03/09/26 | CN¥8.950 | -0.44% | 7,139,912 |
| 02/09/26 | CN¥8.990 | -1.32% | 8,945,172 |
| 01/09/26 | CN¥9.110 | +2.36% | 13,886,372 |
| 31/08/26 | CN¥8.900 | -1.87% | 12,887,680 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 002728 Stock
Select your edition
All financial news and data tailored to specific country editions
